Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
40 Gray in 5 Fractions for Salvage Reirradiation of Spine Lesions Previously Treated With Stereotactic Body Radiotherapy.
Moore A, Zhang Z, Fei T, Zhang L, Accomando L, Schmitt AM, Higginson DS, Mueller BA, Zinovoy M, Gelblum DY, Yerramilli D, Xu AJ, Brennan VS, Guttmann DM, Grossman CE, Dover LL, Shaverdian N, Pike LRG, Cuaron JJ, Dreyfuss A, Lis E, Barzilai O, Bilsky MH, Yamada Y. Moore A, et al. Among authors: dreyfuss a. Neurosurgery. 2024 Aug 1;95(2):380-391. doi: 10.1227/neu.0000000000002889. Epub 2024 Mar 8. Neurosurgery. 2024. PMID: 38456696
Locoregional Control Benefit of a Tumor Bed Boost for Ductal Carcinoma In Situ.
Dreyfuss AD, Max D, Flynn J, Zhang Z, Gillespie EF, Xu A, Cuaron J, Mueller B, Khan AJ, Cahlon O, Powell SN, McCormick B, Braunstein LZ. Dreyfuss AD, et al. Adv Radiat Oncol. 2023 Apr 24;8(5):101254. doi: 10.1016/j.adro.2023.101254. eCollection 2023 Sep-Oct. Adv Radiat Oncol. 2023. PMID: 37250283 Free PMC article.
Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer.
Moore A, Kollmeier MA, McBride SM, Toumbacaris N, Zhang Z, Lacy-Elsayegh A, Dreyfuss A, Grossman CE, Gorovets D, Zelefsky MJ. Moore A, et al. Among authors: dreyfuss a. Eur Urol Oncol. 2024 Aug;7(4):812-820. doi: 10.1016/j.euo.2023.10.019. Epub 2023 Nov 10. Eur Urol Oncol. 2024. PMID: 37949730 Clinical Trial.
Proton Reirradiation for Locoregionally Recurrent Breast Cancer.
LaRiviere MJ, Dreyfuss A, Taunk NK, Freedman GM. LaRiviere MJ, et al. Among authors: dreyfuss a. Adv Radiat Oncol. 2021 May 9;6(4):100710. doi: 10.1016/j.adro.2021.100710. eCollection 2021 Jul-Aug. Adv Radiat Oncol. 2021. PMID: 34409209 Free PMC article.
Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation?
Wright CM, Dreyfuss AD, Baron JA, Maxwell R, Mendes A, Barsky AR, Doucette A, Svoboda J, Chong EA, Jones JA, Maity A, Plastaras JP, Paydar I. Wright CM, et al. Among authors: dreyfuss ad. Adv Radiat Oncol. 2022 Jul 3;7(6):101016. doi: 10.1016/j.adro.2022.101016. eCollection 2022 Nov-Dec. Adv Radiat Oncol. 2022. PMID: 36420208 Free PMC article.
A Prospective Phase I/II Clinical Trial of High-Dose Proton Therapy for Chordomas and Chondrosarcomas.
Dastgheyb SS, Dreyfuss AD, LaRiviere MJ, Mohiuddin JJ, Baumann BC, Shabason J, Lustig RA, Dorsey JF, Lin A, Grady SM, O'Malley BW, Lee JYK, Newman JG, Schuster JM, Alonso-Basanta M. Dastgheyb SS, et al. Among authors: dreyfuss ad. Adv Radiat Oncol. 2024 Feb 8;9(5):101456. doi: 10.1016/j.adro.2024.101456. eCollection 2024 May. Adv Radiat Oncol. 2024. PMID: 38550376 Free PMC article.
74 results